Clinical Trials Browser

Phase 2 × Acquired Immunodeficiency Syndrome × 1 year × Clear all

Acquired Immunodeficiency Syndrome, Neoplasms, Carcinoma, Merkel Cell, Encephalitis, Viral

NCT06519994 2026-05-14

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Phase 2 Completed

120 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT04141449 2025-12-31

Potlako+

Phase 2 Active not recruiting

874 enrolled

BreastGastrointestinalGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Acquired Immunodeficiency Syndrome, Anus Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Neoplasms, Vulvar Neoplasms

NCT00006436 2025-12-30

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

Phase 2 Completed

68 enrolled 24 charts

Lymphoid

Acquired Immunodeficiency Syndrome, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related

NCT07090174 2025-10-01

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

Phase 2 Not yet recruiting

27 enrolled

GastrointestinalGynecologic

Acquired Immunodeficiency Syndrome, Anus Neoplasms, Uterine Cervical Neoplasms

Clinical Trials

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Potlako+

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV